BioFactors
Profiling of lysophosphatidylethanolamine molecular species in human serum and in silico prediction of the binding site on albumin
BioFactors, Volume 48, Issue 5, Page 1076-1088, September/October 2022.
BioFactors
Growth differentiation factor‐15 is independently associated with metabolic syndrome and hyperglycemia in non‐elderly subjects
BioFactors, Volume 49, Issue 1, Page 119-126, January/February 2023.
BioFactors
PDIA4, a novel ER stress chaperone, modulates adiponectin expression and inflammation in adipose tissue
BioFactors, Volume 48, Issue 5, Page 1060-1075, September/October 2022.
BioFactors
Three months of combination therapy with nano‐curcumin reduces the inflammation and lipoprotein (a) in type 2 diabetic patients with mild to moderate coronary artery disease: Evidence of a randomized, double‐blinded, placebo‐controlled clinical trial
BioFactors, Volume 49, Issue 1, Page 108-118, January/February 2023.
BioFactors
Altered type I collagen networking in osteoporotic human femoral head revealed by histomorphometric and Fourier transform infrared imaging correlated analyses
BioFactors, Volume 48, Issue 5, Page 1089-1110, September/October 2022.
BioFactors
A mechanistic review on immunomodulatory effects of selective type two cannabinoid receptor β‐caryophyllene
BioFactors, Volume 48, Issue 4, Page 857-882, July/August 2022.
BioFactors
Nrf2 driven macrophage responses in diverse pathophysiological contexts: Disparate pieces from a shared molecular puzzle
BioFactors, Volume 48, Issue 4, Page 795-812, July/August 2022.
BioFactors
Molecular modeling and in vitro studies of gedunin a potent alpha‐amylase inhibitor and alpha‐glucosidase inhibitor
BioFactors, Volume 48, Issue 5, Page 1118-1128, September/October 2022.